http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
張進凱(Zhang Jinkai),趙海川(Zhao Haichuan) 중국어문학연구회 2021 중국어문학논집 Vol.- No.127
This research adopts the logistic regression model fitted on richly annotated corpus data to investigate the constraining factors of “X BUBI Y · Z”“X MEIYOU Y · Z”and their effect sizes. Conditional inference tree and random forest models are also utilized to analyze the multiple interaction effects between constraints and their relative importance. The results show that the factors such as the positive and negative meanings of the conclusion, the semantic class of the compared item, the position of the comparison point, the type of the conclusion, the word length, register and the semantic class of the compared item significantly influence the constructional choice of “X BUBI Y · Z”and “X MEIYOU Y · Z”.
Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine
( Nan Mu ),( Nannan Liu ),( Qiang Hao ),( Yujin Xu ),( Jialin Li ),( Weina Li ),( Shouzhen Wu ),( Cun Zhang ),( Haichuan Su ) 생화학분자생물학회 2014 BMB Reports Vol.47 No.7
B7-H4 is a member of B7 family of co-inhibitory molecules and B7-H4 protein is found to be overexpressed in many human cancers and which is usually associated with poor survival. In this study, we developed a therapeutic vaccine made from a fusion protein composed of a tetanus toxoid (TT) T-helper cell epitope and human B7-H4IgV domain (TT-rhB7-H4IgV). We investigated the anti-tumor effect of the TT-rhB7-H4IgV vaccine in BALB/c mice and SP2/0 myeloma growth was significantly suppressed in mice. The TT-rhB7-H4IgV vaccine induced high-titer specific antibodies in mice. Further, the antibodies induced by TT-rhB7-H4IgV vaccine were capable of depleting SP2/0 cells through complement-dependent cytotoxicity (CDC) in vitro. On the other hand, the poor cellular immune response was irrelevant to the therapeutic efficacy. These results indicate that the recombinant TT-rhB7-H4IgV vaccine might be a useful candidate of immunotherapy for the treatment of some tumors associated with abnormal expression of B7-H4. [BMB Reports 2014; 47(7): 399-404]